Gian Kayser

University of Freiburg

Papers

1

Total Citations

30

H-Index

1

About

Gian Kayser is a leading figure in urologic oncology, whose research has fundamentally advanced the precision of prostate cancer diagnostics. His work centers on the integration of multiparametric MRI and transrectal ultrasound (TRUS) to improve cancer detection, particularly in challenging patient populations. Kayser’s major contribution lies in validating robot-guided, software-based transperineal MRI/TRUS fusion biopsy as a superior alternative to traditional systematic approaches. In his landmark 2016 study, he demonstrated that this technique achieves significantly higher diagnostic accuracy in high-risk men with prior negative biopsies—a group notoriously difficult to assess. This work, which has garnered over 30 citations, established a new standard for targeted biopsy protocols, reducing false negatives and unnecessary repeat procedures. Kayser’s research directly addresses the clinical dilemma of occult prostate cancer, offering a reproducible, minimally invasive solution that enhances both sensitivity and patient safety. His findings have been instrumental in shifting practice patterns toward fusion-guided approaches, cementing his reputation as a pioneer in image-guided urologic intervention.

Research Focus

Key Achievements

1
H-Index
1
Papers
30
Total Citations
30
Avg Citations/Paper
🏆 Most Cited Paper
Diagnostic Accuracy of Robot-Guided, Software Based Transperineal MRI/TRUS Fusion Biopsy of the Prostate in a High Risk Population of Previously Biopsy Negative Men
30 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: University of Freiburg

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago